World

Top 413 largest Companies in the Drug Manufacturers—Specialty & Generic industry in the World by Market Cap

This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry in the world by market capitalization with links to their reference stock.

World Drug Manufacturers—Specialty & Generic Industry Analysis
World Top Companies World Companies Analysis

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jul. 01, 2025

Rank Company Market Cap (USD) Country Sector Industry
301 The Valens Company Inc. $60.7 M

(Jan. 1, 2023)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
302 Morishita Jintan Co. Ltd $60.4 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
303 Shedir Pharma Group S.p.A. $57.7 M

(Jan. 1, 2025)

 Italy Italian Healthcare Italian Drug Manufacturers—Specialty & Generic
304 Solasia Pharma K.K. $56.3 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
305 SymBio Pharmaceuticals Ltd $56.0 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
306 ECO Animal Health Group plc $55.9 M United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
307 Icanic Brands Co, Inc. $54.1 M

(Feb. 1, 2023)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
308 Diurnal Group plc $53.3 M

(Oct. 1, 2022)

 United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
309 InnoCan Pharma Corp $51.6 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
310 Enzymatica AB $40.5 M

(July 1, 2024)

 Sweden Swedish Healthcare Swedish Drug Manufacturers—Specialty & Generic
311 Shield Therapeutics plc $39.4 M United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
312 Eagle Pharmaceuticals, Inc. $38.9 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
313 Next Science Limited $38.8 M

(July 1, 2024)

 Australia Australian Healthcare Australian Drug Manufacturers—Specialty & Generic
314 Qilian International Holding Group Limited $38.7 M

(Oct. 1, 2024)

 China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
315 Fusen Pharmaceutical Company Ltd $35.8 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
316 iAnthus Capital Holdings, Inc. $33.7 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
317 Anxo Pharmaceutical Co. Ltd $32.7 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
318 MariMed, Inc. $31.9 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
319 Cronos Australia Limited $31.2 M

(July 1, 2024)

 Australia Australian Healthcare Australian Drug Manufacturers—Specialty & Generic
320 SCYNEXIS, Inc. $28.5 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
321 Provexis plc $27.9 M United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
322 PT Indofarma $24.1 M Indonesia Indonesian Healthcare Indonesian Drug Manufacturers—Specialty & Generic
323 Relmada Therapeutics, Inc. $20.9 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
324 Comvita Ltd $19.6 M New Zealand NZ Healthcare NZ Drug Manufacturers—Specialty & Generic
325 Medical Developments International Limited $19.0 M

(July 1, 2024)

 Australia Australian Healthcare Australian Drug Manufacturers—Specialty & Generic
326 Leviathan Cannabis Group, Inc. $18.6 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
327 ProPhase Labs, Inc. $17.4 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
328 Teligent, Inc. $16.1 M

(June 1, 2022)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
329 Mithra Pharmaceuticals SA $15.5 M

(July 1, 2024)

 Belgium Belgian Healthcare Belgian Drug Manufacturers—Specialty & Generic
330 Flora Growth Corp $13.4 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jul. 01, 2025

301. The Valens Company Inc.

Company Profile: The Valens Company Inc.
Market Cap (USD): $60.7 M (Jan. 1, 2023)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

302. Morishita Jintan Co. Ltd

Company Profile: Morishita Jintan Co. Ltd
Market Cap (USD): $60.4 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

303. Shedir Pharma Group S.p.A.

Company Profile: Shedir Pharma Group S.p.A.
Market Cap (USD): $57.7 M (Jan. 1, 2025)
Country: Italy
Sector: Italian Healthcare
Industry: Italian Drug Manufacturers—Specialty & Generic

304. Solasia Pharma K.K.

Company Profile: Solasia Pharma K.K.
Market Cap (USD): $56.3 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

305. SymBio Pharmaceuticals Ltd

Company Profile: SymBio Pharmaceuticals Ltd
Market Cap (USD): $56.0 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

306. ECO Animal Health Group plc

Company Profile: ECO Animal Health Group plc
Market Cap (USD): $55.9 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

307. Icanic Brands Co, Inc.

Company Profile: Icanic Brands Co, Inc.
Market Cap (USD): $54.1 M (Feb. 1, 2023)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

308. Diurnal Group plc

Company Profile: Diurnal Group plc
Market Cap (USD): $53.3 M (Oct. 1, 2022)
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

309. InnoCan Pharma Corp

Company Profile: InnoCan Pharma Corp
Market Cap (USD): $51.6 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

310. Enzymatica AB

Company Profile: Enzymatica AB
Market Cap (USD): $40.5 M (July 1, 2024)
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Drug Manufacturers—Specialty & Generic

311. Shield Therapeutics plc

Company Profile: Shield Therapeutics plc
Market Cap (USD): $39.4 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

312. Eagle Pharmaceuticals, Inc.

Company Profile: Eagle Pharmaceuticals, Inc.
Market Cap (USD): $38.9 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

313. Next Science Limited

Company Profile: Next Science Limited
Market Cap (USD): $38.8 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Drug Manufacturers—Specialty & Generic

314. Qilian International Holding Group Limited

Company Profile: Qilian International Holding Group Limited
Market Cap (USD): $38.7 M (Oct. 1, 2024)
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

315. Fusen Pharmaceutical Company Ltd

Company Profile: Fusen Pharmaceutical Company Ltd
Market Cap (USD): $35.8 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

316. iAnthus Capital Holdings, Inc.

Company Profile: iAnthus Capital Holdings, Inc.
Market Cap (USD): $33.7 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

317. Anxo Pharmaceutical Co. Ltd

Company Profile: Anxo Pharmaceutical Co. Ltd
Market Cap (USD): $32.7 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

318. MariMed, Inc.

Company Profile: MariMed, Inc.
Market Cap (USD): $31.9 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

319. Cronos Australia Limited

Company Profile: Cronos Australia Limited
Market Cap (USD): $31.2 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Drug Manufacturers—Specialty & Generic

320. SCYNEXIS, Inc.

Company Profile: SCYNEXIS, Inc.
Market Cap (USD): $28.5 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

321. Provexis plc

Company Profile: Provexis plc
Market Cap (USD): $27.9 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

322. PT Indofarma

Company Profile: PT Indofarma
Market Cap (USD): $24.1 M
Country: Indonesia
Sector: Indonesian Healthcare
Industry: Indonesian Drug Manufacturers—Specialty & Generic

323. Relmada Therapeutics, Inc.

Company Profile: Relmada Therapeutics, Inc.
Market Cap (USD): $20.9 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

324. Comvita Ltd

Company Profile: Comvita Ltd
Market Cap (USD): $19.6 M
Country: New Zealand
Sector: NZ Healthcare
Industry: NZ Drug Manufacturers—Specialty & Generic

325. Medical Developments International Limited

Company Profile: Medical Developments International Limited
Market Cap (USD): $19.0 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Drug Manufacturers—Specialty & Generic

326. Leviathan Cannabis Group, Inc.

Company Profile: Leviathan Cannabis Group, Inc.
Market Cap (USD): $18.6 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

327. ProPhase Labs, Inc.

Company Profile: ProPhase Labs, Inc.
Market Cap (USD): $17.4 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

328. Teligent, Inc.

Company Profile: Teligent, Inc.
Market Cap (USD): $16.1 M (June 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

329. Mithra Pharmaceuticals SA

Company Profile: Mithra Pharmaceuticals SA
Market Cap (USD): $15.5 M (July 1, 2024)
Country: Belgium
Sector: Belgian Healthcare
Industry: Belgian Drug Manufacturers—Specialty & Generic

330. Flora Growth Corp

Company Profile: Flora Growth Corp
Market Cap (USD): $13.4 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

Stay in touch